| Acquired factor V inhibitors: a systematic review. | |
| | |
MedLine Citation:
|
PMID: 21052780 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The occurrence of an inhibitor against coagulation factor V (FV) is a rare but challenging condition, which may span from asymptomatic laboratory abnormalities to potentially life-threatening bleeding. The onset of FV inhibitors has been associated most frequently in the past with the patients' exposure to topical bovine thrombin administered during surgery procedures. However, since this preparation is no longer used, in this systematic review we have only focused on non-bovine thrombin-related FV inhibitor cases. |
| | |
Authors:
|
Massimo Franchini; Giuseppe Lippi |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of thrombosis and thrombolysis Volume: 31 ISSN: 1573-742X ISO Abbreviation: J. Thromb. Thrombolysis Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-05-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9502018 Medline TA: J Thromb Thrombolysis Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 449-57 Citation Subset: IM |
Affiliation:
|
Servizio di Immunoematologia e Medicina Trasfusionale, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy, mfranchini@ao.pr.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: GFT projection NMR spectroscopy for proteins in the solid state.
Next Document: Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy.